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Nicotinic acetylcholine receptors (nAChRs) are targets of
general anesthetics, but functional sensitivity to anesthetic inhibition varies dramatically among different subtypes of nAChRs.
Potential causes underlying different functional responses to
anesthetics remain elusive. Here we show that in contrast to the
␣7 nAChR, the ␣7␤2 nAChR is highly susceptible to inhibition
by the volatile anesthetic isoflurane in electrophysiology measurements. Isoflurane-binding sites in ␤2 and ␣7 were found at
the extracellular and intracellular end of their respective transmembrane domains using NMR. Functional relevance of the
identified ␤2 site was validated via point mutations and subsequent functional measurements. Consistent with their functional responses to isoflurane, ␤2 but not ␣7 showed pronounced dynamics changes, particularly for the channel gate
residue Leu-249(9ⴕ). These results suggest that anesthetic binding alone is not sufficient to generate functional impact; only
those sites that can modulate channel dynamics upon anesthetic
binding will produce functional effects.

Neuronal nicotinic acetylcholine receptors (nAChRs)2 are
pentameric ligand-gated ion channels (pLGICs) that mediate
the fast synaptic response in the central and peripheral nervous
systems. They are composed of ␣ (␣2–␣10) and ␤ (␤2–␤4) sub-
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units and assemble to form either homo- or hetero-pLGICs.
The ␣7 subunit mainly forms homo-pLGICs, but it can also
assemble with ␤2 or ␤3 subunits to form hetero-pLGICs (1–3).
nAChRs have been implicated in general anesthesia and play
roles in memory (4), nociception (5), and the autonomic
response (6). Different subtypes of nAChRs show distinct sensitivities to general anesthetics (7–9), even though they share
high sequence homology. For instance, the ␣7 nAChR is insensitive to volatile anesthetics at clinically relevant concentrations, whereas the ␣4␤2 nAChR is hypersensitive (8, 9). The
underlying cause, however, remains elusive.
High resolution structures of the full-length neuronal
nAChRs, including ␣4␤2 and ␣7, have not been solved. However, NMR structures for the TM domains of ␣4, ␤2, and ␣7
subunits have been recently determined (Protein Data Bank
codes 2LLY, 2LM2, and 2MAW) (10). The 4 Å resolution cryoelectron microscopy structure of the Torpedo marmorata
nAChR (11) reveals overall structural features of nAChRs.
Each subunit has an extracellular (EC) domain containing
the orthosteric ligand binding site, a transmembrane (TM)
domain composed of four TM helices, of which TM2 lines
the pore and contains the channel gate, and an intracellular
(IC) domain. High resolution x-ray structures of bacterial
homologues from Gloebacter violaceous (GLIC) and Erwinia
chrysanthemi (ELIC) demonstrate the same structural scaffold (12–18).
Previously, we investigated potential causes for different
sensitivities of the ␣4␤2 and ␣7 nAChRs to volatile general
anesthetics using molecular dynamics simulations (19 –21).
Although multiple anesthetic binding sites were observed in
␣7, ␣4, and ␤2 subunits, anesthetic binding to a site at the interface between EC and TM domains of ␤2 produced a profound
change in protein dynamics that was likely to affect channel
function. On the basis of the simulation results, we proposed
that the susceptibility to anesthetic perturbation in ␤2, but not
in ␣7, underlies the functional sensitivity of ␣4␤2 and insensitivity of ␣7 to volatile anesthetics (19). We also predicted that
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Background: What determines hypersensitivity or insensitivity of ␤2-containing or ␣7 nAChRs to volatile anesthetics
remains unclear.
Results: Isoflurane binds to the EC end of the TM domain, modulates channel dynamics, and inhibits channel current in ␤2 not ␣7.
Conclusion: The dynamic and structural differences between ␤2 and ␣7 affect isoflurane binding and inhibition.
Significance: Both structure and dynamics are critical for drug action.

Determinants of Functional Sensitivity to Anesthetics

EXPERIMENTAL PROCEDURES
Electrophysiology Measurements—Neuron dissociation and
patch clamp whole cell current recordings were performed as
reported previously (3). Briefly, several 400-m coronal slices
from postnatal Wistar rats (2–3 weeks old) containing the ventral diagonal band (VDB) or the ventral tegmental area (VTA)
were cut in cold (2– 4 °C) artificial cerebrospinal fluid. The
slices were incubated for at least 1 h in oxygenated artificial
cerebrospinal fluid at room temperature (22 ⫾ 1 °C). Thereafter, the slices were treated with Pronase (1 mg/6 ml) at 31 °C for
30 min. The medial septum/diagonal band or VTA region was
micropunched out from the slices using a well polished needle.
Each punched piece was then dissociated mechanically using
several fire-polished micro-Pasteur pipettes in a 35-mm culture
dish filled with well oxygenated, standard external solution (150
mM NaCl, 5 mM KCl, 1 mM MgCl2, 2 mM CaCl2, 10 mM glucose,
and 10 mM HEPES, pH 7.4, with Tris-base). The separated single cells usually adhered to the bottom of the dish within 30
min. Human ␣7-nAChR was expressed heterologously in transfected SH-EP1 human epithelial cells as described in detail previously (22).
Functional measurements were performed using perforated
patch whole cell recordings coupled with a two-barrel drug
application system (3). After the formation of whole cell configuration, an access resistance less than 30 M⍀ was acceptable
for voltage-clamp recordings. The series resistance was not
compensated in the experiments using dissociated neurons.
The data were filtered at 2 kHz, acquired at 11 kHz, and digitized on-line (Digidata 1322 series A/D board; Axon Instruments, Foster City, CA). All experiments were done at room
temperature (22 ⫾ 1 °C). Clampex 9.2 (Axon Instruments) was
used for data acquisition, and Prism 3.0 (Prismsoft Inc.) was
used for graphics and statistical calculation. For statistical analysis of multiple groups of data, one-way or multivariate analysis
of variance followed by appropriate test was applied. p ⬍ 0.05
was considered significant, and the data are represented as
mean ⫾ S.E.
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To ascertain the different sensitivity of ␣7␤2 and ␣7 to isoflurane observed in neurons, we also used Xenopus laevis
oocytes for channel expression and functional measurements.
The plasmids encoding human ␣7 and ␤2 nAChRs for oocyte
expression were gifts from Prof. Lindstrom’s lab at the University of Pennsylvania and Prof. Henry Lester’s lab at the California Institute of Technology, respectively. To reconcile the
structural and functional data, we constructed two mutants
(␣7-M22⬘V and ␣7␤2-V22⬘M) for functional measurements in
oocytes. The mutations were introduced by QuikChange lightning site-directed mutagenesis kit (Agilent) and confirmed
by DNA sequencing. cRNAs were synthesized for ␣7 and
␣7-M261V(M22⬘V) with the mMessage mMachine SP6 kit
(Ambion) and for ␤2 and ␤2-V22⬘M with the mMessage
mMachine T7 kit (Ambion). The cRNAs were purified with the
RNeasy kit (Qiagen).
Channel functions of Xenopus laevis oocytes (stages 5– 6)
expressing native and mutant nAChRs were measured by twoelectrode voltage clamp experiments. For making ␣7␤2, the
RNAs of ␣7 and ␤2 were injected to each oocyte in a 1:1 ratio
with a total of 25 ng. The injected oocytes were maintained at
18 °C in a modified Barth’s solution (17). After being expressed
for 24 –36 h, the oocyte in a 20-l recording chamber (Automate Scientific) and the ND96 buffer (23) was clamped with an
OC-725C Amplifier (Warner Instruments) to a holding potential of ⫺60 mV, and currents elicited by acetylcholine and
modulated by 50-M isoflurane were recorded. The collected
data were processed using Clampex 10 software (Molecular
Devices).
NMR Experiments—NMR samples of the TM domains of the
␣7 and ␤2 human nAChRs were prepared using the protocols
as reported in detail previously (10). Each NMR sample at pH
4.7 contained 0.25– 0.3 mM protein, 40 – 60 mM lauryldimethylamine-oxide (LDAO) detergent, 5 mM sodium acetate, 10 mM
NaCl, 20 mM 2-mercaptoethanol to prevent disulfide bond formation, and 5% D2O for deuterium lock in NMR measurements. The
anesthetic isoflurane was titrated into the samples using a gas tight
microsyringe. The isoflurane concentration was quantified based
on 19F NMR using the method reported previously (24).
All NMR spectra were acquired on a Bruker Avance 600
MHz spectrometer, which was equipped with a triple-resonance inverse detection TCI cryoprobe (Bruker Instruments,
Billerica, MA). 1H-15N TROSY-HSQC spectra were acquired
with 1-s relaxation delay for each sample before and after adding isoflurane. Spectral windows were typically 13 ppm (1,024
data points) in the 1H dimension and 22 ppm (128 data points)
in the 15N dimension. The 1H chemical shifts were referenced
to the DSS resonance at 0 ppm, and the 15N chemical shifts
were indirectly referenced (25).
The collected NMR data were processed using NMRPipe 4.1
and NMRDraw 1.8 (26) and analyzed using Sparky 3.10 (27).
Each processed spectrum had 4,096 ⫻ 512 data points. 1H and
15
N chemical shift assignments for the ␣7 and ␤2 TM domains
in the presence of isoflurane were referenced to the previous
assignments for the same proteins without drugs (10). Chemical shifts and peak intensities in the NMR spectra were measured using Sparky 3.10 (27).
VOLUME 288 • NUMBER 50 • DECEMBER 13, 2013
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unlike ␣7, ␣7␤2 would be sensitive to volatile anesthetics
because of the involvement of ␤2 (19).
In the present study, we revealed different functional
responses of the ␣7␤2 and ␣7 nAChRs, expressed in neurons
and Xenopus laevis oocytes, to the anesthetic isoflurane. We
also determined the binding sites and dynamic effects of isoflurane on both the ␣7 and ␤2 nAChR TM domains using NMR,
validated the functional relevance of the identified isoflurane
site via point mutations and subsequent functional measurements, and rationalized potential causes underlying the insensitivity of the ␣7 channel and the hypersensitivity of the ␣7␤2
channel to isoflurane. The study provides compelling evidence
that isoflurane binds to both ␣7 and ␤2, but at different locations. More importantly, isoflurane binding induced pronounced dynamics changes in ␤2, particularly for the channel
gate residue Leu-249(9⬘). In contrast, isoflurane binding to ␣7
did not generate the same dynamics changes. The study conveys a message that only those sites able to modulate protein
dynamics upon anesthetic binding will produce functional
effects.

Determinants of Functional Sensitivity to Anesthetics

SE p ⫽ Sp
where
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冑

冑

1
1
⫹
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共n1 ⫺ 1兲s12 ⫹ 共n2 ⫺ 1兲s22
n1 ⫹ n2 ⫺ 2

(Eq. 1)

(Eq. 2)

and where n1 and n2 represent the two sample sizes, and s1 and
s2 represent the two standard deviations.

RESULTS
The ␣7␤2 nAChR Is Much More Sensitive to Isoflurane Inhibition Than the ␣7 nAChR—Our previous pharmacological,
cell biological, and single-cell RT-PCR studies confirmed the
expression, localization, and assembly of ␣7␤2 nAChRs in VDB
neurons (3). Here, we used the same dissociated VDB neurons
to test functional responses of ␣7␤2 nAChRs to the volatile
anesthetic isoflurane. As shown in Fig. 1, the inward currents
were generated by application of 10 mM choline, an agonist for
␣7-containing nAChRs, in acutely dissociated neurons from
mouse VDB at a holding potential of ⫺60 mV. The peak currents were significantly reduced by 10 M isoflurane after 2 min
of isoflurane preincubation. Isoflurane preincubation reduced
the maximal choline-induced activation by 37 ⫾ 8%. The EC50
DECEMBER 13, 2013 • VOLUME 288 • NUMBER 50

FIGURE 1. Isoflurane inhibited function of the ␣7␤2 but not ␣7 nAChRs. a,
the ␣7␤2 nAChRs expressed in VDB neurons were noncompetitively inhibited by 2 min of preincubation with 10 M isoflurane (Iso). EC50 of choline
(Cho) and Hill coefficients show no significant differences in the absence and
presence of isoflurane. b, isoflurane inhibited ␣7␤2 with an IC50 of 11.7 ⫾ 1.6
M. Fractional currents were obtained from the mean peak currents elicited
by 10 mM choline (⬃EC70). The error bars are standard errors (n ⫽ 6). c, representative whole cell current traces for ␣7␤2 expressed in VDB neurons, native
␣7 in VTA neurons, and heterologously human ␣7 nAChRs in the SH-EP1 cells.
The vertical and horizontal scales represent 50 pA and 250 ms, respectively. d,
normalized mean (⫾ S.E.) peak current responses of ␣7␤2 and ␣7 expressed
in various cells to the prolonged choline stimulation in the presence of 10 M
isoflurane (n ⫽ 6). Isoflurane inhibited choline-induced currents in ␣7␤2, but
not in ␣7. e– h, representative current traces for ␣7␤2 (e), ␣7 (f), the ␣7-M22⬘V
mutant (g), and the ␣7␤2-V22⬘M mutant (h) expressed in Xenopus oocytes.
The currents were elicited by acetylcholine at the EC20, modulated by isoflurane (50 M), and recorded by two-electrode voltage clamp at ⫺60 mV. The
vertical and horizontal scales represent 25 nA and 1 min, respectively.

and Hill coefficient had no significant changes (p ⫽ 0.58) in the
absence (3.8 ⫾ 0.3 mM; 1.35 ⫾ 0.32) and presence (4.1 ⫾ 0.5
mM; 1.23 ⫾ 0.18) of 10 M isoflurane, suggesting that isoflurane
inhibition occurs in a noncompetitive manner (Fig. 1a). Isoflurane inhibition of ␣7␤2-nAChR-mediated whole cell current in
acutely dissociated neurons from mouse VDB was concentration-dependent with an IC50 of 11.7 ⫾ 1.6 M (Fig. 1b), less than
0.1 minimum alveolar concentration in human (31, 32). We
JOURNAL OF BIOLOGICAL CHEMISTRY
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Visualization of Isoflurane Binding and Calculation of Cavity
Volumes and Angles between TM2 and TM4—To assist visualizing isoflurane-binding sites identified by NMR experiments,
we performed docking of isoflurane to NMR structures of the
␣7 and ␤2 TM domains. The targeted docking kept only those
sites consistent with the NMR results. Docking was performed
with Autodock4 (28) using a Lamarckian genetic algorithm
with a grid spacing of 0.375 Å. For each intrasubunit binding
site suggested by the NMR data, 250 independent anesthetic
dockings were performed within a cube covering ⬃6,600 Å3
using an initial population size of 500.
The sizes of intersubunit cavities for isoflurane binding were
calculated using the POVME algorithm (29). A grid encompassing the cavity in each of the 20 NMR structures of ␣7 or ␤2
was generated with 0.5 Å grid spacing. The algorithm provided
the grid points defining the cavity, which represent a subset of
the total cavity points. Using MATLAB威, we determined the
frequency that each point was observed in the bundle of 20
NMR structures for ␣7 or ␤2. Points shown from at least five
structures were used for highlighting the cavity in Fig. 3.
Reported cavity volumes are the means ⫾ S.E. of the volumes
calculated for the 20 NMR structures. The VMD program (30)
was used for visualizing molecular structures and generating
figures.
The angles between TM2 and TM4 helices near the EC end
of the TM domain were calculated for each of 20 structures for
␤2 or ␣7. Vectors were fit to backbone atoms of TM2 (residues
from Lys-260 to Leu-249 in ␤2 and from Glu-259 to Leu-248 in
␣7) and TM4 (residues from Leu-454 to Phe-443 in ␤2 and
from Met-466 to Val-455 in ␣7). Angles were calculated using
the cross product of the two vectors. The values reported are
the mean differences between the ␤2 and ␣7 angles ⫾ the
pooled standard error, SEP,

Determinants of Functional Sensitivity to Anesthetics

measured isoflurane inhibition by using a repeated application
protocol, in which choline was applied at 2-min intervals in the
continuous presence of 10 M isoflurane. Isoflurane progressively inhibited ␣7␤2 currents. Reversibility of isoflurane inhibition was demonstrated by the current recovery after 4 min of
isoflurane washout. In contrast to ␣7␤2, the homomeric ␣7
expressed either in neurons dissociated from VTA (33) or in the
SH-EP1 cells (22) are not sensitive to 10 M isoflurane (Fig. 1, c
and d). This is consistent with an IC50 of ⬃600 M (⬃2 minimum alveolar concentration) for the human ␣7 nAChR
reported previously (34). Different sensitivities to isoflurane
inhibition were also observed in the recombinant ␣7␤2 and ␣7
nAChRs expressed in Xenopus laevis oocytes. Representative
current traces obtained from oocytes (Fig. 1, e and f) echo the
message conveyed by the results from the dissociated neurons
(Fig. 1, a– d). In addition, we found that a swap of residue 22⬘
between ␣7 and ␤2 had a dramatic impact on isoflurane inhibition (Fig. 1, g and h). Although ␣7 is insensitive to isoflurane
inhibition, the mutant ␣7-M261(22⬘)V showed 39 ⫾ 7% (n ⫽ 6)
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isoflurane inhibition, similar to that (46 ⫾ 3%, n ⫽ 4) observed
on ␣7␤2. Conversely, the mutant ␣7␤2-V262(22⬘)M, similar to
␣7, showed a lower sensitivity to isoflurane inhibition (12 ⫾ 2%,
n ⫽ 4). Altogether, these data suggest an indispensible role for
␤2 and the importance of its residue Val-262(22⬘) in isoflurane
inhibition.
␤2 and ␣7 Have Different Isoflurane-binding Sites in Their
TM Domains—We investigated the binding sites of isoflurane
in the TM domains of ␤2 and ␣7 nAChRs using high resolution
NMR. As shown in the 1H-15N TROSY-HSQC spectra (Fig. 2, a
and b), the presence of 1.3 or 1.6 mM isoflurane perturbed a
number of residues in ␤2 or ␣7 nAChRs, respectively. The residues with either more than 40% intensity change or a combined chemical shift change (35) greater than 15 ppb (␤2) and
10 ppb (␣7) were mapped onto NMR structures of the ␤2 or ␣7
TM domains (Fig. 2, c and d). Intrasubunit pockets for isoflurane binding were found in the NMR structures of ␤2 and ␣7,
but at different sites: the one in ␣7 is close to the intracellular
end of the TM domain, and the one in ␤2 is at the EC end of the
VOLUME 288 • NUMBER 50 • DECEMBER 13, 2013
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FIGURE 2. Isoflurane binding to the TM domains of ␤2 and ␣7. a and b, 1H-15N TROSY-HSQC spectra of ␤2 (a) and ␣7 (b) in the presence (green) and absence
(black) of 1.3 or 1.6 mM isoflurane, respectively. Residues showing significant changes in chemical shift or peak intensity are labeled and highlighted with red.
Residues labeled in blue are pore-lining residues. Full chemical shift assignments for ␤2 and ␣7 TM domains are provided in supplemental Figs. S1 and S2,
respectively. c, the bundle of 20 NMR structures of the ␤2 TM domain (Protein Data Bank code 2LM2) mapped with residues highlighted in red in a. d, the bundle
of 20 NMR structures of the ␣7 TM domain (Protein Data Bank code 2MAW) mapped with residues highlighted in red in b. Residues are colored based on residue
type: green, polar; white, nonpolar; and blue, basic. Docked isoflurane is shown in magenta.

Determinants of Functional Sensitivity to Anesthetics

FIGURE 3. The intrasubunit cavity at the EC end of the TM domain in ␤2, but not in ␣7, can accommodate isoflurane binding. a, alignment of 20 NMR
structures with the lowest target function for ␤2 (blue) and ␣7 (yellow), and the cavities of ␤2 (blue) and ␣7 (red), outlined by grid points present in at least five
of the 20 structures. b and c, residues highlighted with the side chain bundles (shown in stick representation) in ␤2 (b) and ␣7 (c) have primary responsibility
for the different cavity volumes. Note that in ␤2, the cavity can accommodate isoflurane (purple surface), but the cavity in ␣7 (dotted outline) cannot do the
same. d, the top view of the lowest target function structures of ␤2 (blue) and ␣7 (yellow) shows different orientations of TM helices.

DECEMBER 13, 2013 • VOLUME 288 • NUMBER 50

upon isoflurane binding, ␣7 retained a single signal for each
residue in the NMR spectra, but ␤2 showed classic examples of
two-site chemical exchange (40, 41) for several residues, including the channel gate residue Leu-249(9⬘) and Val-262(22⬘) lining the isoflurane-binding pocket in ␤2. As shown in Fig. 4, in
the absence of isoflurane (black), each of these ␤2 residues
showed a single peak in the NMR spectrum. After adding 1.3
mM isoflurane (red), an additional peak became observable for
Leu-248 and Thr-265 (denoted as Leu-248⬘ and Thr-265⬘,
respectively). When the isoflurane concentration was increased
to 3 mM (cyan), Leu-249 and Val-262 also showed additional
peaks. The combined chemical shift change between each pair
of peaks (A-B or A⬘-B), ⌬H⫹N ⫽ [(⌬H2 ⫹ ⌬N2)]1⁄2 is 32, 27,
37, 32 Hz for Leu-248, Leu-249, Val-262, and Thr-265 of ␤2,
respectively. Based on the consensus from many previous studies (40 – 42), the occurrence of two distinct peaks for a residue
indicates a slow exchange with kex ⬍⬍ 2⌬H⫹N ⬃ 200 s⫺1.
Conformational exchange among ␤2 residues also shows
some differences. For residues Leu-248 and Thr-265, peak A
remained at 20-Hz line width and the same resonance frequency in the absence and presence of isoflurane, indicating a
possibility that slow conformational exchange with an
extremely low population for the second conformation (peak B)
already existed in the absence of isoflurane. Isoflurane shifted
the equilibria between the two conformations. Indeed, the population of conformation B, pB ⫽ 1 ⫺ pA, increased from 0 to
⬃0.3 and more than ⬃0.5 when isoflurane was increased from 0
to 1.3 and 3 mM. Overall, Leu-248 and Thr-265 fit well to the
scheme of slow exchange between two conformations (40 – 42).
In the case of Leu-249 and Val-262, however, a single peak with
a broader line width in the 1H dimension was observed in the
presence of 0 mM (Leu-249, 21 Hz; Val-262, 17 Hz) and 1.3 mM
isoflurane (Leu-249, 19 Hz; Val-262, 16 Hz), but two narrower
peaks (Leu-249, 16 and 12 Hz; Val-262, 14 and 12 Hz) were
observed in the presence of 3 mM isoflurane. The results suggest
that Leu-249 and Val-262 were likely in an intermediate
exchange regime (40, 41) before being exposed to 3 mM isoflurane. In addition to slower exchange between A⬘ and B conformations, the increased isoflurane concentration also shifted
peak A⬘ from peak A by 14 and 11 Hz for Leu-249 and Val-262,
respectively (Fig. 4). This is not unexpected, considering that
multiple conformers with subtle differences can coexist in a
functional state (43, 44). The sensitivity of ␤2 and insensitivity
of ␣7 to the dynamics modulation by isoflurane are in good
agreement with their distinctly different functional responses
to isoflurane inhibition.
JOURNAL OF BIOLOGICAL CHEMISTRY
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TM domain, which is also the site for halothane and ketamine
binding (36). Moreover, this anesthetic site in ␤2 is homologous
to the previously identified anesthetic site in GLIC (37), ELIC
(18), and the Torpedo nAChR (38). The isoflurane site in ␣7 is
homologous to a halothane binding site at the IC end of the ␤2
TM domain identified by NMR and coincides with one of the
halothane sites in ␣7 predicted by our previous molecular
dynamics simulations (19).
Some residues, including the channel gate residue Leu249(9⬘) in ␤2, showed significant changes upon the addition of
isoflurane but are structurally remote from the cluster of residues defining the binding pocket. Their changes likely result
from allosteric effects rather than direct contact with isoflurane. It is also worth noting that several pore-lining residues in
␤2, but not ␣7, showed greatly reduced intensity upon the addition of isoflurane, indicative of motional changes for these
residues.
A Smaller Intrasubunit Pocket Excludes Isoflurane Binding to
the EC end of the ␣7 TM Domain—To determine why isoflurane binds to the EC end of the TM domain in ␤2 but not in ␣7,
we examined the pocket in this region based on NMR structures of the ␤2 and ␣7 TM domains. Mostly hydrophobic residues and a few hydrophilic residues from four TM helices line
the intrasubunit pocket near the EC end of the TM helices in
both ␤2 and ␣7. The average cavity volumes are 179 ⫾ 12 and
122 ⫾ 10 Å3 for ␤2 and ␣7, respectively (Fig. 3). The differences
in cavity volume primarily result from tighter packing of four
helices in the region of ␣7 and greater side chain volume of
several cavity-lining residues in ␣7, such as ␣7-M261(22⬘) versus ␤2-V262(22⬘), ␣7-I271 versus ␤2-V272, and ␣7-F275 versus
␤2-L276. The differences in isoflurane inhibition made by these
residues were evident in functional measurements of the
mutants ␣7-M261(22⬘)V and ␣7␤2-V262(22⬘)M (Fig. 1, g and
h). Helical tilting differences (6.7 ⫾ 1.3°), measured by angles
between TM2 and TM4 (Fig. 3d), also contribute to different
cavity volumes at the EC end of the TM domain between ␤2 and
␣7. Both the inward helical tilting of ␣7 and the more bulky
M22⬘ side chain in ␣7 contribute to a smaller cavity. Furthermore, orientations of side chains also affect the cavity volumes.
For the residues in TM3, both side chains of ␤2-V272 and
␤2-L276 are oriented away from the cavity, whereas the equivalent residues ␣7-I271 and ␣7-F275 are oriented toward the
cavity. A smaller cavity in the EC end of the TM domain in ␣7
has reduced the probability of isoflurane binding to the region,
considering that isoflurane has a volume of 144 Å3 (39).
Isoflurane Modulates the Dynamics of ␣7 and ␤2 Differently—
One of the most striking differences between ␣7 and ␤2 is that
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DISCUSSION
Our functional data substantiate the previous prediction (19)
that, unlike the ␣7 nAChR, the ␣7␤2 nAChR is sensitive to
anesthetic inhibition. The result highlights the role of ␤2 in
functional modulation by volatile anesthetics and supports our
hypothesis that ␤2 is primarily responsible for the difference of
anesthetic susceptibility between ␣4␤2 and ␣7 (19). More
importantly, the result conveys the message that two or three
subunits susceptible to anesthetics, such as ␤2 in ␣7␤2, are
sufficient to produce functional effects. The message is consistent with the notion obtained from molecular dynamics simulations of anesthetic propofol action in GLIC (45).
Why is ␤2 more susceptible to volatile anesthetics than ␣7?
This key question has been addressed by our NMR experiments
from three aspects. First, ␤2 and ␣7 show some structural differences in their TM domains, even though they share a common scaffold. The most notable difference lies in the size of an
intrasubunit cavity near the EC end of the TM domain that is
large enough in ␤2, but not in ␣7, to accommodate isoflurane
binding. Second, the structural difference leads to different
binding locations for isoflurane, which binds to the cavity at the
EC end of the TM domain in ␤2 but to a pocket located at the IC
end of the TM domain in ␣7. Finally, differences in their structures and isoflurane-binding sites may have contributed to different dynamics responses of ␤2 and ␣7 to isoflurane binding.
Only in ␤2 were isoflurane-induced changes in conformational
populations and motion on the s-ms time scale observed. The
combined effects from structures, anesthetic binding sites, and
dynamics modulations may have contributed to the functional
differences between ␤2 and ␣7.
The sequence identity between ␤2 and ␣7 is high, ⬃50% for
the TM domain and close to 65% for the pore-lining TM2 helix.
Their sequence homology is even higher (Fig. 5). Our results
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FIGURE 5. Sequence alignments for TM domains of human ␣7 and ␤2
nAChRs. Sequences of the constructs used for NMR samples, ␣7⬘ and ␤2⬘, are
aligned with their respective native sequences. Note that only a few terminal
and loop residues were changed to increase the stability of NMR samples. The
labeled sequence numbers are for the ␣7 nAChR. The pore lining residues are
labeled using the conventional prime numbering. Residues in the box were
mutated in the study.

demonstrate that variation in a small number of residues is
sufficient to make differences in protein structures, drug-binding sites, and functional responses to drug binding. The functional significance of such small changes in structure highlights
the necessity of solving individual protein structures, even for
highly homologous proteins. In the case of ␤2 and ␣7, the
homologous cavity-lining residues ␤2-V22⬘ and ␣7-M22⬘ make
a notable difference for their respective cavities, isoflurane
binding, and isoflurane inhibition. Indeed, a single ␣7-M22⬘V
mutation markedly increased the channel sensitivity to isoflurane, and the ␣7␤2-V22⬘M mutation had a reverse effect. This
result is consistent with the diminished sensitivity to volatile
anesthetics observed previously for the I22⬘M mutation in the
␣3 containing nAChR (46). A larger volume and extended side
VOLUME 288 • NUMBER 50 • DECEMBER 13, 2013
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FIGURE 4. Different dynamics responses of ␤2 and ␣7 to isoflurane modulation. Overlay of NMR spectra for individual residues in ␤2 (a– d) and ␣7 (e– h) in
the presence of isoflurane: 0 mM (black), 1.3 mM for ␤2 and 1.6 mM for ␣7 (red), and 3.0 mM for ␤2 and 3.3 mM for ␣7 (cyan). Note that none of the ␣7 residues show
an additional conformation over the isoflurane concentration range used in the experiments. The peaks representing the different conformations for ␤2 are
labeled A, A⬘, and B.
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Our study not only highlights the importance of the anesthetic binding site but also emphasizes the role of channel
dynamics in anesthetic action. Although ␤2 and ␣7 have high
sequence homology, the dynamics and subtle structural differences are sufficient to affect anesthetic binding as well as functional consequences. Anesthetic binding is necessary but not
sufficient to produce a functional consequence. Only the binding that modulates dynamics of pore-lining residues, such as
that at the EC end of the ␤2 TM domain, can impact function.
Acknowledgments—The plasmids encoding human ␣7 and ␤2
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chain conformation of Met-22⬘ can effectively reduce the cavity
volume and obstruct drug binding. Moreover, methionine may
also stabilize the TM2 helix and make it more resilient to structural and dynamic perturbation introduced by anesthetic binding. Previous studies using unnatural amino acid substitutions
have shown that residues with unbranched side chains, such as
methionine and alanine, have a more stabilizing effect on ␣
helices than branched amino acids, such as valine and isoleucine (47). Similarly, ␤2-S19⬘ and ␣7-A19⬘ could also make
dynamics differences to the TM2 helix. Alanine is a natural
helix promoter (48), whereas serine and threonine often disrupt
␣-helices because of backbone to side chain hydrogen bonds
(49, 50). Our previous NMR study noted heightened conformational dynamics at the EC end of TM2 for the glycine receptor,
which is uniquely rich with serines in this region compared with
other pLGICs (51). Contributions to the anesthetic binding site
from two pairs of residues in TM3, ␤2-L276/␣7-F275 and
␤2-V272/␣7-I271, should also not be underestimated. Mutation on the homologous residue in GLIC was found to significantly affect the susceptibility of the channel to the anesthetics
desflurane and propofol (37).
The anesthetic binding site at the EC end of the TM domain,
as revealed for isoflurane in ␤2, is probably a common site in
pLGICs for anesthetics. Using NMR, we found that the anesthetics halothane and ketamine bound to the same site in ␤2
(36). The site is also consistent with one of the halothane sites
identified by photo affinity labeling in the Torpedo nAChR (38)
and by fluorescence quenching in GLIC (52). The anesthetics
desflurane and propofol were found in the homologous site in
the crystal structures of GLIC bound with these anestethics
(37). Functional and mutation studies on the ␣7/␣3 nAChR
chimeras also underscored the importance of the cavity to inhibition by the volatile anesthetic halothane (46). In contrast,
anesthetic binding to the IC end of the TM domain, as observed
for isoflurane in ␣7 in this study, is less effective to perturb
channel function. Isoflurane inhibits ␣7 only at concentrations
higher than those used clinically (34).
Our results provide evidence that functional insensitivity of
␣7 to volatile anesthetics is not due to a lack of anesthetic binding, at least in the case of isoflurane. The hypersensitivity of
␣7␤2 and the insensitivity of ␣7 suggest that the EC end of the
TM domain plays a critical role for channel gating in pLGICs.
Increasing the rigidity of residues at the EC end of the TM
domain can make the channel less responsive to activation signals. Many previous studies support this notion. Increasing helical flexibility at the EC end of TM2 of the nAChR was found to
increase the sensitivity of the receptors to agonist more than
10-fold (53). Disulfide bond trapping experiments on the
GABAA receptor (54) and EPR experiments on GLIC (55) also
support heightened dynamics at the EC end of TM2 during
channel gating. Our previous work on the glycine receptor
suggested that increasing or decreasing the conformational
dynamics at the EC end of TM2 could respectively increase or
decrease the susceptibility of the channel to allosteric modulation (51). Thus, it is conceivable that changing dynamics of the
EC end of the TM domain, either via drug binding or via point
mutations, is a common mechanism to modulate the functions
of pLGICs.

Determinants of Functional Sensitivity to Anesthetics

35800 JOURNAL OF BIOLOGICAL CHEMISTRY

34. Flood, P., and Coates, K. M. (2002) Sensitivity of the ␣7 nicotinic acetylcholine receptor to isoflurane may depend on receptor inactivation.
Anesth. Analg. 95, 83– 87
35. Schumann, F. H., Riepl, H., Maurer, T., Gronwald, W., Neidig, K. P., and
Kalbitzer, H. R. (2007) Combined chemical shift changes and amino acid
specific chemical shift mapping of protein-protein interactions. J. Biomol.
NMR 39, 275–289
36. Bondarenko, V., Mowrey, D., Liu, L. T., Xu, Y., and Tang, P. (2013) NMR
resolved multiple anesthetic binding sites in the TM domains of the ␣4␤2
nAChR. Biochim. Biophys. Acta 1828, 398 – 404
37. Nury, H., Van Renterghem, C., Weng, Y., Tran, A., Baaden, M., Dufresne,
V., Changeux, J. P., Sonner, J. M., Delarue, M., and Corringer, P. J. (2011)
X-ray structures of general anaesthetics bound to a pentameric ligandgated ion channel. Nature 469, 428 – 431
38. Chiara, D. C., Dangott, L. J., Eckenhoff, R. G., and Cohen, J. B. (2003)
Identification of nicotinic acetylcholine receptor amino acids photolabeled by the volatile anesthetic halothane. Biochemistry 42, 13457–13467
39. Jenkins, A., Greenblatt, E. P., Faulkner, H. J., Bertaccini, E., Light, A., Lin,
A., Andreasen, A., Viner, A., Trudell, J. R., and Harrison, N. L. (2001)
Evidence for a common binding cavity for three general anesthetics within
the GABAA receptor. J. Neurosci. 21, RC136
40. Mittermaier, A. K., and Kay, L. E. (2009) Observing biological dynamics at
atomic resolution using NMR. Trends Biochem. Sci. 34, 601– 611
41. Kleckner, I. R., and Foster, M. P. (2011) An introduction to NMR-based
approaches for measuring protein dynamics. Biochim. Biophys. Acta
1814, 942–968
42. Palmer, A. G., 3rd, Kroenke, C. D., and Loria, J. P. (2001) Nuclear magnetic
resonance methods for quantifying microsecond-to-millisecond motions
in biological macromolecules. Methods Enzymol. 339, 204 –238
43. Prevost, M. S., Sauguet, L., Nury, H., Van Renterghem, C., Huon, C.,
Poitevin, F., Baaden, M., Delarue, M., and Corringer, P. J. (2012) A locally
closed conformation of a bacterial pentameric proton-gated ion channel.
Nat. Struct. Mol. Biol. 19, 642– 649
44. Yamodo, I. H., Chiara, D. C., Cohen, J. B., and Miller, K. W. (2010) Conformational changes in the nicotinic acetylcholine receptor during gating
and desensitization. Biochemistry 49, 156 –165
45. Mowrey, D., Cheng, M. H., Liu, L. T., Willenbring, D., Lu, X., Wymore, T.,
Xu, Y., and Tang, P. (2013) Asymmetric Ligand Binding Facilitates Conformational Transitions in Pentameric Ligand-Gated Ion Channels. J. Am.
Chem. Soc. 135, 2172–2180
46. Downie, D. L., Vicente-Agullo, F., Campos-Caro, A., Bushell, T. J., Lieb, W. R.,
and Franks, N. P. (2002) Determinants of the anesthetic sensitivity of neuronal
nicotinic acetylcholine receptors. J. Biol. Chem. 277, 10367–10373
47. Lyu, P. C., Sherman, J. C., Chen, A., and Kallenbach, N. R. (1991) ␣-helix
stabilization by natural and unnatural amino acids with alkyl side chains.
Proc. Natl. Acad. Sci. U.S.A. 88, 5317–5320
48. Richardson, J. S., and Richardson, D. C. (1988) Amino acid preferences for
specific locations at the ends of ␣ helices. Science 240, 1648 –1652
49. Ballesteros, J. A., Deupi, X., Olivella, M., Haaksma, E. E., and Pardo, L.
(2000) Serine and threonine residues bend ␣-helices in the 1 ⫽ g(⫺)
conformation. Biophys. J. 79, 2754 –2760
50. Varga, Z., and Kovacs, A. (2005) Hydrogen bonding in peptide secondary
structures. Int. J. Quant. Chem. 105, 302–312
51. Mowrey, D. D., Cui, T., Jia, Y., Ma, D., Makhov, A. M., Zhang, P., Tang, P.,
and Xu, Y. (2013) Open-channel structures of the human glycine receptor
␣1 full-length transmembrane domain. Structure 21, 1897–1904
52. Chen, Q., Cheng, M. H., Xu, Y., and Tang, P. (2010) Anesthetic binding in
a pentameric ligand-gated ion channel. GLIC. Biophys. J. 99, 1801–1809
53. England, P. M., Zhang, Y., Dougherty, D. A., and Lester, H. A. (1999)
Backbone mutations in transmembrane domains of a ligand-gated ion
channel. Implications for the mechanism of gating. Cell 96, 89 –98
54. Horenstein, J., Wagner, D. A., Czajkowski, C., and Akabas, M. H. (2001)
Protein mobility and GABA-induced conformational changes in GABAA
receptor pore-lining M2 segment. Nat. Neurosci. 4, 477– 485
55. Velisetty, P., Chalamalasetti, S. V., and Chakrapani, S. (2012) Conformational transitions underlying pore opening and desensitization in membrane-embedded Gloeobacter violaceus ligand-gated ion channel (GLIC).
J. Biol. Chem. 287, 36864 –36872

VOLUME 288 • NUMBER 50 • DECEMBER 13, 2013

Downloaded from http://www.jbc.org/ at ELSEVIER BV on September 19, 2019

14. Pan, J., Chen, Q., Willenbring, D., Mowrey, D., Kong, X.-P., Cohen, A.,
Divito, C. B., Xu, Y., and Tang, P. (2012) Structure of the pentameric
ligand-gated ion channel GLIC bound with anesthetic ketamine. Structure
20, 1463–1469
15. Sauguet, L., Poitevin, F., Murail, S., Van Renterghem, C., Moraga-Cid, G.,
Malherbe, L., Thompson, A. W., Koehl, P., Corringer, P. J., Baaden, M.,
and Delarue, M. (2013) Structural basis for ion permeation mechanism in
pentameric ligand-gated ion channels. EMBO J. 32, 728 –741
16. Hilf, R. J., and Dutzler, R. (2008) X-ray structure of a prokaryotic pentameric ligand-gated ion channel. Nature 452, 375–379
17. Pan, J., Chen, Q., Willenbring, D., Yoshida, K., Tillman, T., Kashlan, O. B.,
Cohen, A., Kong, X. P., Xu, Y., and Tang, P. (2012) Structure of the pentameric ligand-gated ion channel ELIC cocrystallized with its competitive
antagonist acetylcholine. Nat. Commun. 3, 714
18. Spurny, R., Billen, B., Howard, R. J., Brams, M., Debaveye, S., Price, K. L.,
Weston, D. A., Strelkov, S. V., Tytgat, J., Bertrand, S., Bertrand, D., Lummis, S. C., and Ulens, C. (2013) Multisite binding of a general anesthetic to
the prokaryotic pentameric Erwinia chrysanthemi ligand-gated ion channel (ELIC). J. Biol. Chem. 288, 8355– 8364
19. Mowrey, D., Haddadian, E. J., Liu, L. T., Willenbring, D., Xu, Y., and Tang,
P. (2010) Unresponsive correlated motion in ␣7 nAChR to halothane
binding explains its functional insensitivity to volatile anesthetics. J. Phys.
Chem. B 114, 7649 –7655
20. Liu, L. T., Willenbring, D., Xu, Y., and Tang, P. (2009) General anesthetic
binding to neuronal ␣4␤2 nicotinic acetylcholine receptor and its effects
on global dynamics. J. Phys. Chem. B 113, 12581–12589
21. Liu, L. T., Haddadian, E. J., Willenbring, D., Xu, Y., and Tang, P. (2010)
Higher susceptibility to halothane modulation in open- than in closedchannel ␣4␤2 nAChR revealed by molecular dynamics simulations. J.
Phys. Chem. B 114, 626 – 632
22. Zhao, L., Kuo, Y. P., George, A. A., Peng, J. H., Purandare, M. S., Schroeder,
K. M., Lukas, R. J., and Wu, J. (2003) Functional properties of homomeric,
human ␣7-nicotinic acetylcholine receptors heterologously expressed in
the SH-EP1 human epithelial cell line. J. Pharmacol. Exp. Ther. 305,
1132–1141
23. Dascal, N. (2001) Voltage clamp recordings from Xenopus oocytes. Current Protocols in Neuroscience (Crawley, J. N., McKay, Ra., and Rogawski,
M. A., eds) Chapter 6, Unit 6.12, John Wiley and Sons, Hoboken, NJ.
24. Xu, Y., Seto, T., Tang, P., and Firestone, L. (2000) NMR study of volatile
anesthetic binding to nicotinic acetylcholine receptors. Biophys. J. 78,
746 –751
25. Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield,
E., Markley, J. L., and Sykes, B. D. (1995) 1H, 13C and 15N chemical shift
referencing in biomolecular NMR. J. Biomol. NMR 6, 135–140
26. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A.
(1995) NMRPipe. A multidimensional spectral processing system based
on UNIX pipes. J. Biomol. NMR 6, 277–293
27. Goddard, T. D., and Kneller, D. G. (2001) SPARKY 3, University of California, San Francisco
28. Morris, G. M., Goodsell, D. S., Halliday, R. S., Huey, R., Hart, W. E., Belew,
R. K., and Olson, A. J. (1998) Automated docking using a Lamarckian
genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639 –1662
29. Durrant, J. D., de Oliveira, C. A., and McCammon, J. A. (2011) POVME.
An algorithm for measuring binding-pocket volumes. J. Mol. Graph.
Model 29, 773–776
30. Humphrey, W., Dalke, A., and Schulten, K. (1996) VMD. Visual molecular
dynamics. J. Mol. Graph. 14, 33–38
31. Yamashita, M., Mori, T., Nagata, K., Yeh, J. Z., and Narahashi, T. (2005)
Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells. Anesthesiology 102, 76 – 84
32. Nickalls, R. W., and Mapleson, W. W. (2003) Age-related iso-MAC charts
for isoflurane, sevoflurane and desflurane in man. Br. J. Anaesth. 91,
170 –174
33. Wu, J., George, A. A., Schroeder, K. M., Xu, L., Marxer-Miller, S., Lucero,
L., and Lukas, R. J. (2004) Electrophysiological, pharmacological, and molecular evidence for ␣7-nicotinic acetylcholine receptors in rat midbrain
dopamine neurons. J. Pharmacol. Exp. Ther. 311, 80 –91

Insights into Distinct Modulation of α7 and α7β2 Nicotinic Acetylcholine
Receptors by the Volatile Anesthetic Isoflurane
David D. Mowrey, Qiang Liu, Vasyl Bondarenko, Qiang Chen, Edom Seyoum, Yan Xu,
Jie Wu and Pei Tang
J. Biol. Chem. 2013, 288:35793-35800.
doi: 10.1074/jbc.M113.508333 originally published online November 5, 2013

Access the most updated version of this article at doi: 10.1074/jbc.M113.508333

Click here to choose from all of JBC's e-mail alerts

Supplemental material:
http://www.jbc.org/content/suppl/2013/11/05/M113.508333.DC1
This article cites 53 references, 13 of which can be accessed free at
http://www.jbc.org/content/288/50/35793.full.html#ref-list-1

Downloaded from http://www.jbc.org/ at ELSEVIER BV on September 19, 2019

Alerts:
• When this article is cited
• When a correction for this article is posted

